Shionogi & Co. Hits Day Low at JPY 3,478 Amid Price Pressure

Shionogi & Co., a prominent player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline today, with its stock price dropping by 3.55% on April 9, 2026. The stock reached an intraday low of JPY 3,478.00, reflecting a challenging trading session compared to the Japan Nikkei 225, which fell by only 0.73% during the same period. Over the past week, Shionogi's performance has been down by 1.86%, contrasting sharply with the Nikkei's gain of 6.54%. However, the company has shown resilience over the longer term, with a year-to-date increase of 22.42%, significantly outperforming the Nikkei's 11.04% rise. Despite this, the stock has faced considerable pressure over the past three and five years, with declines of 41.74% and 40.55%, respectively. Financially, Shionogi maintains a strong position with a healthy EBIT to Interest ratio of 55.35, indicating robust debt servicing capabilities. The company reported impressive quarterly results, including record net sales and operating profit, contributing to a return on equity of 12.45%. As a large-cap entity with a market capitalization of JPY 2,546,572 million, Shionogi continues to navigate a competitive landscape while delivering solid financial metrics.